{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2"}]}],"title":"Severe Regimen Related Toxicity (RRT)"},{"categories":[{"measurements":[{"groupId":"OG000","value":"5"}]}],"title":"Nonrelapse mortality at 2 years"}],"denoms":[{"counts":[{"groupId":"OG000","value":"60"}],"units":"Participants"}],"description":"Proportion of patients experiencing regimen-related toxicity to major organ systems from day minus 6 to day 28. Major organ systems: cardiac, bladder/renal, pulmonary, hepatic, neurologic and gastrointestinal","groups":[{"description":"Conditioning with Treosulfan (12 or 14 g/m2, IV for 5 days) and Fludarabine (30 mg/m2, IV for 5 days) followed by Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies","id":"OG000","title":"Treosulfan and Fludarabine Conditioning"}],"paramType":"NUMBER","reportingStatus":"POSTED","timeFrame":"34 days and 2 years","title":"Number of Patients Experiencing Regimen-related Toxicity Events in Study Population","type":"PRIMARY","unitOfMeasure":"participants"}